Delivery Order SPE2DB22D2206-SPE2DB25FKA33
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,543.70 for 60 tablets of Lynparza 100 mg on July 30, 2025, with an ultimate completion date of August 20, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a continuation of pharmaceutical supply services under AmerisourceBergen's broader federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Lynparza 150 mg tablets (120-count units) with a firm fixed price ceiling value of $21,135.20 and ultimate completion date of September 10, 2025. This delivery order represents a non-competitive award and is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $21,135.20 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Lynparza 150 mg tablets (120-count units). This firm fixed price, non-set-aside contract is scheduled for completion by October 17, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $10,519.62 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Lynparza 100 mg tablets (120-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 30, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $42,270.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Lynparza 150 mg tablets (120-count units) on August 12, 2025, with an ultimate completion date of September 3, 2025. This non-competitive delivery order is being fulfilled from AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of LYNPARZA 150 mg tablets (60-count unit dose) with a ceiling value of $10,499.34. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lynparza 150 mg tablets (120 count units) with a contract value of $10,567.60. This firm fixed-price delivery order, awarded on September 15, 2025, is expected to be completed by October 6, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $10,567.60, for the supply of LYNPARZA 150 mg tablets (120-count units) on September 23, 2025. This firm fixed-price delivery order, with an ultimate completion date of October 15, 2025, was competitively awarded without a set-aside designation. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $31,702.80 on June 16, 2025, for the supply of Lynparza 150 mg tablets (120-count units). This firm fixed-price, competitively awarded contract has a completion date of July 9, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified pharmaceutical distributors. This...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Lynparza 100 mg tablets (120-count packages) valued at $10,519.62, with completion targeted for September 30, 2025. This non-compete award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion global pharmaceutical support vehicle designated SPE2DX and running through December 2026....
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKA33Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $42,270.40 for Lynparza 150 mg tablets (120-count units) on September 22, 2025, with an ultimate completion date of October 14, 2025. This firm fixed-price, non-competitive set-aside contract is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal military and veteran healthcare systems, AmerisourceBergen fulfills extensive medical supply needs through the DLA's global pharmaceutical support program. This delivery order for Lynparza, a specialty oncology medication, exemplifies the company's role in supplying brand-name pharmaceuticals across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems. The IDC vehicle enables flexible ordering of pharmaceutical products and medical supplies to military healthcare programs worldwide, with the DLA currently planning to expand the Pharmaceutical Prime Vendor Global Program through multiple regional awards involving several contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.3k | 9/22/25 |